Previous reports have demonstrated that chymase inhibition significantly reduced MMP-9 levels and attenuated the severity of acute inflammatory diseases, such as indomethacin-induced small intestinal inflammation and acute liver failure [10,11]. The gene discussed is MMP9; the disease is acute liver failure.